Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Drug Pricing

February 14, 2018 | Daily News

CMS actuaries expect Medicare and Medicaid to see faster growth in spending between 2017 and 2026 than private insurance, in part because baby boomers will be aging out of the private insurance market and into Medicare and a higher share of older and disabled Medicaid beneficiaries will contribute to faster spending in that program.

February 13, 2018 | Daily News

The president’s budget proposes $16 million in user fees to help the Health Resources and Services Administration administer the 340B drug discount program, a proposal one lobbyist said could end up serving as an offset if lawmakers look to make changes to the program.

February 12, 2018 | Daily News

The president's budget request includes drug-price chopping policies that CMS could accomplish administratively, including proposals to let groups of states negotiate prices using closed formularies and to change the reimbursement of doctors who administer drugs.

February 12, 2018 | Daily News

The White House is taking on what it views as anticompetitive behavior by some generic drug companies that stave off additional generic entrants by being first to file and then “parking” exclusivity by failing to market their product.

February 09, 2018 | Daily News

Nonprofit hospitals say a new report on drug pricing that is critical of the 340B program, along with a reported proposal from HHS Secretary Alex Azar to tie 340B reimbursement to charity care, shows the administration doesn't understand the 340B drug discount program, while other lobbyists say the report may be setting up both the president's upcoming budget request and 340B reform bills on Capitol Hill.

February 09, 2018 | Daily News

A newly released Council of Economic Advisors report on drug pricing, which is expected to inform HHS' fiscal 2019 budget request, is angering both public health advocates and those favoring sweeping drug pricing reforms, given it suggests FDA can lower drug prices by speeding FDA approvals of brand drugs and making FDA's approval standards easy to comply with, all while making no mention of brand industry-opposed reforms, including those that have been floated by FDA Commissioner Scott Gottlieb, such as cracking down on abuses of FDA-mandated safety programs.

February 09, 2018 | Daily News

HHS Secretary Alex Azar’s plan to curb rising drug prices includes reforms to hospital 340B drug discounts and cuts to Medicare doctor pay similar those that the Obama CMS withdrew in the face of rabid attacks by drug companies, according to a lobbyist.

February 08, 2018 | Daily News

HHS Secretary Alex Azar is about to release a plan to curb rising drug prices that involves Medicare Part D and Medicaid policies focused on shining a light on drug-channel middlemen and lowering beneficiary drug spending at the pharmacy counter, lobbyists say.

February 08, 2018 | Daily News

Senators tout their budget deal for closing the Part D donut hole a year early, but the more significant result of the bill for beneficiaries is that it would lower drug premiums, according to Jack Hoadley, a congressional Medicare adviser and policy analyst for Georgetown University’s Health Policy Institute.

February 08, 2018 | Daily News

Senate Aging Committee Chair Susan Collins (R-ME) raised concerns during a committee hearing Wednesday (Feb. 7) over price hikes associated with two of the world’s best-selling drugs, both of which treat Rheumatoid Arthritis (RA), as well as the patent thicket that has kept lower-price competitors off the market.

February 07, 2018 | Daily News

The bipartisan budget deal announced by Senate Majority Leader Mitch McConnell (R-KY) and Minority Leader Charles Schumer (D-NY) on Wednesday (Feb. 7) includes four additional years of funding for the Children's Health Insurance Program; funding for community health centers, teaching health centers and the National Health Service Corps; repeal of the therapy caps; a delay of the Medicaid Disproportionate Share Hospital pay cuts and funding for other so-called Medicare extenders, according to a Democratic overview of the deal and draft bill language obtained by Inside Health Policy.

February 07, 2018 | Daily News

Drug lobbyists and policy analysts say the Senate budget deal includes a Medicare Part D offset that the brand drug industry strongly opposes, but they say the details of the measures are unclear because they are written in a way that is difficult to decipher.

February 01, 2018 | Daily News

The advocates behind Patients for Affordable Drugs have launched a new organization, which will spend seven figures in the 2018 midterm elections to support candidates that back drug pricing reform.

February 01, 2018 | Daily News

FDA came under fire from Rep. Buddy Carter (R-GA) Tuesday (Jan. 30) for what he alleges is the agency's use of guidance documents as the basis for compounding enforcement actions.

January 31, 2018 | Daily News

Senate Finance Chair Orrin Hatch (R-UT) asked new HHS Secretary Alex Azar to consider moving the 340B drug discount program from the Health Resources and Services Administration, which has run the program since its inception, to CMS.

January 31, 2018 | Daily News

President Donald Trump said during the State of the Union speech that he has directed his administration to cut drug prices, but the one measure the Trump CMS has taken on drug prices will have the opposite effect, according to nonpartisan congressional Medicare advisers, and Trump gave no indication of how he plans to go about lowering prices. Some Republicans said they’re a little concerned by the statement, but others say they agree the government should control prices and they think boosting generics is the way to do it.

January 30, 2018 | Daily News

President Donald Trump in his first State of the Union Address trumpeted the repeal of Obamacare's individual mandate; repeated his vow to cut prescription drug prices; held up FDA's increased approval of new and generic drugs and medical devices; asked Congress to pass “Right to Try” legislation giving patients immediate access to experimental drugs; and pledged to fight the opioid epidemic.

January 30, 2018 | Daily News

The health care sector was abuzz Tuesday (Jan. 30) over news that Amazon, JP Morgan and Berkshire Hathaway will partner to create a new healthcare entity, and while traditional health insurance stocks took a dive following the announcement, as did those of pharmacy benefit managers, health experts and analyst said it was too early to speculate on how the entity would impact the health space.

January 26, 2018 | Daily News

Circumstances are good for administrative changes to Part B drug reimbursement, former Obama administration official Kavita Patel said, and Pew Charitable Trusts Senior Director of Health Programs Allan Coukell said newly confirmed HHS chief Alex Azar has a few tools he could use to curb drug-spending increases without help from Congress.

January 26, 2018 | Daily News

A bipartisan group of 20 senators is urging CMS to move forward with its informal proposal to make plans share drug rebates with consumers and ban pharmacy price concessions, but Republican chairs of Senate and House committees warn CMS against making those policy changes without going through the public rulemaking process.

Pages